Aerpio Pharmaceuticals Commences Trading on the OTCQB Market


Aerpio Pharmaceuticals announced that shares of the company’s common stock have been cleared for trading on the OTC Market Group's OTCQB market in the United States. Shares of Aerpio’s common stock will trade under the ticker symbol "ARPO," effective at the market open on August 8, 2017.

In March 2017, Aerpio raised approximately $40 million in gross proceeds through a private placement of the company’s common stock to further clinical development activities, including advancement of Aerpio’s lead program, AKB-9778, for the treatment of diabetic retinopathy (DR).

Related Content